Literature DB >> 23474519

Dabigatran overdose secondary to acute kidney injury and amiodarone use.

Christos Fountzilas1, Jerry George, Randy Levine.   

Abstract

Oral direct thrombin inhibitors have improved treatment of non-valvular atrial fibrillation. Safety concerns have been raised since there is no antidote for treatment of secondary haemorrhages and the absence of widely validated test to monitor drug levels. We present a case of dabigatran overdose in an 82-year-old female who was treated with a seemingly appropriate dose.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23474519

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


  9 in total

Review 1.  Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Authors:  Julie Kalabalik; Gail B Rattinger; Jesse Sullivan; Malgorzata Slugocki; Antonia Carbone; Anastasia Rivkin
Journal:  Drugs       Date:  2015-06       Impact factor: 9.546

Review 2.  Enhanced elimination of dabigatran through extracorporeal methods.

Authors:  Nadia I Awad; Luigi Brunetti; David N Juurlink
Journal:  J Med Toxicol       Date:  2015-03

Review 3.  Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.

Authors:  Amish N Raval; Joaquin E Cigarroa; Mina K Chung; Larry J Diaz-Sandoval; Deborah Diercks; Jonathan P Piccini; Hee Soo Jung; Jeffrey B Washam; Babu G Welch; Allyson R Zazulia; Sean P Collins
Journal:  Circulation       Date:  2017-02-06       Impact factor: 29.690

Review 4.  Oral anticoagulants and risk of nephropathy.

Authors:  Vinay Narasimha Krishna; David G Warnock; Nakshatra Saxena; Dana V Rizk
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

5.  Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients.

Authors:  Heather L Forbes; Thomas M Polasek
Journal:  Ther Adv Drug Saf       Date:  2017-07-11

6.  Coagulopathy and Extremely Elevated PT/INR after Dabigatran Etexilate Use in a Patient with End-Stage Renal Disease.

Authors:  Joonseok Kim; Mrinal Yadava; In Chul An; Abrar Sayeed; Heather S Laird-Fick; Venu Gourineni; George S Abela
Journal:  Case Rep Med       Date:  2013-09-18

Review 7.  Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.

Authors:  Allison E Burnett; Charles E Mahan; Sara R Vazquez; Lynn B Oertel; David A Garcia; Jack Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

Review 8.  Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence.

Authors:  Kristine C Willett; Amanda M Morrill
Journal:  Ther Clin Risk Manag       Date:  2017-04-06       Impact factor: 2.423

9.  Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older Adults.

Authors:  Kevin Hill; Ewa Sucha; Emily Rhodes; Sarah Bota; Gregory L Hundemer; Edward G Clark; Mark Canney; Ziv Harel; Tzu-Fei Wang; Marc Carrier; Harindra C Wijeysundera; Greg Knoll; Manish M Sood
Journal:  CJC Open       Date:  2021-11-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.